To support the supply of safe and effective medicines, consideration must be given to the stability of the ingredients and the product during the development, manufacture, storage, distribution and use of pharmaceutical products.
This symposium will explore critical issues encountered in both hospital and industry with medicines designed for special populations. The techniques used to characterise and
understand pharmaceutical systems, and approaches that can be taken to predict stability will be described. Speakers will discuss stability issues and concerns encountered during the development and supply of biological products, with medicines for paediatrics, during manufacture of aseptic products and in the provision of other unlicensed medicines.
The programme includes contributions from key industrial, hospital, academic and regulatory speakers.
This symposium will explore critical issues encountered in both hospital and industry with medicines designed for special populations. The techniques used to characterise and
understand pharmaceutical systems, and approaches that can be taken to predict stability will be described. Speakers will discuss stability issues and concerns encountered during the development and supply of biological products, with medicines for paediatrics, during manufacture of aseptic products and in the provision of other unlicensed medicines.
The programme includes contributions from key industrial, hospital, academic and regulatory speakers.
